Shoulder Innovations (SI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Executive summary
Annual meeting scheduled for June 26, 2026, with voting available online or virtually.
Shareholders are encouraged to review proxy materials and vote by June 25, 2026.
Voting matters and shareholder proposals
Election of Class I directors, with Robert Ball and Andrew Hykes nominated.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Board recommends voting in favor of all proposals.
Other business may be addressed if properly brought before the meeting.
Board of directors and corporate governance
Board recommends the election of two Class I director nominees.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Shoulder Innovations
- Annual meeting to elect directors and ratify auditor, with strong governance and risk oversight.SI
Proxy filing29 Apr 2026 - Q4 revenue up 65% and 2026 guidance targets 31–37% growth, driven by innovation and ASC momentum.SI
Q4 202510 Mar 2026 - Innovative implants and AI-driven planning fuel rapid growth and high margins in shoulder arthroplasty.SI
Investor presentation10 Mar 2026 - AI-driven innovation and outpatient focus fuel strong growth and new opportunities in shoulder arthroplasty.SI
2026 CG Musculoskeletal Conference4 Mar 2026 - Disruptive InSet Glenoid and AI-driven platform fuel rapid growth in shoulder arthroplasty.SI
Investor presentation3 Mar 2026 - AI-driven planning and streamlined implants drive growth as ASC adoption accelerates.SI
Jefferies London Healthcare Conference 20253 Feb 2026 - 33% Q2 growth fueled by efficient two-tray system, ASC focus, and commercial scaling.SI
Morgan Stanley 23rd Annual Global Healthcare Conference31 Dec 2025 - Portable robotics and surgeon-focused innovation fuel rapid growth and strong margins.SI
Piper Sandler 37th Annual Healthcare Conference13 Dec 2025 - IPO seeks $88M to scale shoulder implant business, fund R&D, and expand in a competitive market.SI
Registration Filing29 Nov 2025